Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.

@article{Gelenberg2000EfficacyOV,
  title={Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.},
  author={Alan J. Gelenberg and Robert Bruce Lydiard and Richard Leslie Rudolph and Leonardo J. G. Aguiar and John Thomas Haskins and Eliseo O. Salinas},
  journal={JAMA},
  year={2000},
  volume={283 23},
  pages={
          3082-8
        }
}
CONTEXT Generalized anxiety disorder (GAD) is a chronic disorder that is associated with debilitating psychic and somatic symptoms. Venlafaxine extended-release (XR) capsules have been shown to be effective in short-term treatment of patients with GAD without major depressive disorder (MDD), but long-term data are needed to establish whether this agent confers persistent benefits. OBJECTIVE To compare the 6-month efficacy and safety of a flexible dosage of venlafaxine XR in outpatients with… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 90 CITATIONS, ESTIMATED 24% COVERAGE

FILTER CITATIONS BY YEAR

1998
2018

CITATION STATISTICS

  • 6 Highly Influenced Citations

  • Averaged 3 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 19 REFERENCES

The relationship between irritable bowel syndrome and psychiatric illness: a family study

CL Woodman, K Breen, R JrNoyes
  • Psychosomatics
  • 1998

Anxiety disorders

CK Kirkwood, PE Hayes
  • eds. Pharmacotherapy. 3rd ed
  • 1997

Importance of establishing the diagnosis of persistent anxiety.

  • The Journal of clinical psychiatry
  • 1997
VIEW 1 EXCERPT

The nature of generalized anxiety disorder and pathological worry: current evidence and conceptual models

TA Brown
  • Can J Psychiatry
  • 1997
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…